Ambagon is discovering and developing small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins.

Analytics

Biotechnology

Ambagon Therapeutics

Ambagon Therapeutics' headquarters in San Francisco, CA, United States

Tanja Meyer

Tom van de Wijngaart

Laura Demmers

Loes Stevers

Donna Olivia Debets

Taggra Jackson

Rens de Vries

Willem van den Hout

Eline Sijbesma

Maarten Altelaar

Carolyn Bertozzi

Alan Ashworth

Steve Davidsen

Geraldine Harriman

Ali Tavassoli

Peter Dudek

Michelle Arkin

Janwillem Naesens

Margarita Chavez

Luc Brunsveld

Description

People (3)

Tanja Meyer

Taggra Jackson

Jinxia Nancy Deng

Jobs